CIK 0000768408 · Non-accelerated filer<br>Smaller reporting company
CYANOTECH CORP
Sign in to watch- Ticker
- CYAN
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 911206026
- Phone
- 8083261353
- Business address
- 73-4460 QUEEN KAAHUMANU HWY, SUITE 102, KAILUA KONA, HI, 96740
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | Johansen Jennifer M. VP, Quality, Regulatory & Govt | Shares withheld for taxes | −1,202 | $0.44 | $529 | 5,981 |
| 2024-02-16 | Johansen Jennifer M. VP, Quality, Regulatory & Govt | Option exercise · Restricted Stock Units | −3,200 | 6,059 | ||
| 2024-02-16 | Kakuk Collette Nicole Chief Strategic Comml Officer | Option exercise | +3,900 | 3,900 | ||
| 2024-02-16 | Kakuk Collette Nicole Chief Strategic Comml Officer | Shares withheld for taxes | −1,556 | $0.44 | $685 | 2,344 |
| 2024-02-16 | Kakuk Collette Nicole Chief Strategic Comml Officer | Option exercise · Restricted Stock Units | −3,900 | 3,900 | ||
| 2024-02-16 | Hartmann Charles Jason VP, Sales & Marketing | Option exercise | +3,900 | 4,949 | ||
| 2024-02-16 | Hartmann Charles Jason VP, Sales & Marketing | Shares withheld for taxes | −1,556 | $0.44 | $685 | 3,393 |
| 2024-02-16 | Hartmann Charles Jason VP, Sales & Marketing | Option exercise · Restricted Stock Units | −3,900 | 7,361 | ||
| 2024-02-16 | Nordin Amy Beth VP, HR, Secretary | Option exercise | +3,400 | 6,161 | ||
| 2024-02-16 | Nordin Amy Beth VP, HR, Secretary | Shares withheld for taxes | −1,277 | $0.44 | $562 | 4,884 |
| 2024-02-16 | Nordin Amy Beth VP, HR, Secretary | Option exercise · Restricted Stock Units | −3,400 | 6,504 | ||
| 2023-12-15 | DAVIS MICHAEL A / Director | Purchase | +400,000 | $1.00 | $400K | 1,046,736 |
| 2023-12-01 | DAVIS MICHAEL A / Director | Purchase | +39,455 | $0.90 | $36K | 646,736 |
| 2023-10-13 | DAVIS MICHAEL A / Director | Grant or award | +12,821 | 607,281 | ||
| 2023-09-15 | DAVIS MICHAEL A / Director | Purchase | +3,245 | $0.85 | $3K | 594,460 |
| 2023-09-14 | DAVIS MICHAEL A / Director | Purchase | +2,253 | $0.83 | $2K | 591,215 |
| 2023-09-13 | DAVIS MICHAEL A / Director | Purchase | +3,245 | $0.83 | $3K | 588,962 |
| 2023-09-12 | Kakuk Collette Nicole Chief Strategic Comml Officer | Grant or award · Cyanotech common stock options | +50,000 | 50,000 | ||
| 2023-09-12 | DAVIS MICHAEL A / Director | Purchase | +107 | $0.79 | $84 | 585,717 |
| 2023-09-11 | DAVIS MICHAEL A / Director | Purchase | +292 | $0.83 | $242 | 585,610 |
Page 10 of 23 · 458 trades